NO20084826L - Ny administrasjonsform av racecadotril - Google Patents

Ny administrasjonsform av racecadotril

Info

Publication number
NO20084826L
NO20084826L NO20084826A NO20084826A NO20084826L NO 20084826 L NO20084826 L NO 20084826L NO 20084826 A NO20084826 A NO 20084826A NO 20084826 A NO20084826 A NO 20084826A NO 20084826 L NO20084826 L NO 20084826L
Authority
NO
Norway
Prior art keywords
racecadotril
administration form
new administration
new
raccoadotril
Prior art date
Application number
NO20084826A
Other languages
English (en)
Other versions
NO342977B1 (no
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084826(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of NO20084826L publication Critical patent/NO20084826L/no
Publication of NO342977B1 publication Critical patent/NO342977B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår en ny racecadotrilformulering i form av tabletter, fremstillingsprosessen derav og anvendelsen derav for å behandle diaré.
NO20084826A 2006-05-15 2008-11-18 Racecadotriltablett, fremgangsmåte for fremstilling av slike og slike tabletter for behandling av diaré NO342977B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.
PCT/FR2007/000814 WO2007132091A1 (fr) 2006-05-15 2007-05-14 Nouvelle forme d'administration du racecadotril

Publications (2)

Publication Number Publication Date
NO20084826L true NO20084826L (no) 2008-12-12
NO342977B1 NO342977B1 (no) 2018-09-17

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084826A NO342977B1 (no) 2006-05-15 2008-11-18 Racecadotriltablett, fremgangsmåte for fremstilling av slike og slike tabletter for behandling av diaré

Country Status (28)

Country Link
US (1) US8318203B2 (no)
EP (1) EP2018158B1 (no)
KR (1) KR101432116B1 (no)
CN (2) CN103961328A (no)
AP (1) AP2627A (no)
AU (1) AU2007251471B2 (no)
BR (1) BRPI0710405B8 (no)
CA (1) CA2652023C (no)
CY (1) CY1114190T1 (no)
DK (1) DK2018158T3 (no)
EA (1) EA014707B1 (no)
EC (1) ECSP088889A (no)
ES (1) ES2421929T3 (no)
FR (1) FR2900823B1 (no)
HR (1) HRP20130624T1 (no)
IL (1) IL195270A (no)
MA (1) MA30466B1 (no)
MX (1) MX2008014554A (no)
NO (1) NO342977B1 (no)
NZ (1) NZ573424A (no)
PL (1) PL2018158T3 (no)
PT (1) PT2018158E (no)
RS (1) RS52912B (no)
SI (1) SI2018158T1 (no)
TN (1) TNSN08428A1 (no)
UA (1) UA98299C2 (no)
WO (1) WO2007132091A1 (no)
ZA (1) ZA200809721B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
EP3086777A1 (en) * 2013-12-23 2016-11-02 Johnson & Johnson Consumer Inc. Racecadotril compositions
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
JP6851973B2 (ja) * 2015-02-09 2021-03-31 リボファーム・エスエーＲｉｖｏｐｈａｒｍ Ｓａ ラセカドトリルの医薬製剤
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
KR102195776B1 (ko) * 2017-03-06 2020-12-29 아테나 파르마쎄티크 에스에이에스 라세카도트릴을 포함하는 약학 조성물 및 이를 제조하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
CN1635884A (zh) * 2000-06-23 2005-07-06 生物计划公司 包含外消旋卡朵曲的干粉制剂
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
EP1563848A1 (en) 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
KR101052436B1 (ko) * 2004-08-13 2011-07-29 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출형 정제 제형, 이의 제조방법 및 이의용도
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Also Published As

Publication number Publication date
AP2008004686A0 (en) 2008-12-31
EA014707B1 (ru) 2011-02-28
HRP20130624T1 (en) 2013-08-31
AU2007251471A1 (en) 2007-11-22
EP2018158B1 (fr) 2013-04-24
NO342977B1 (no) 2018-09-17
TNSN08428A1 (fr) 2010-04-14
CN103961328A (zh) 2014-08-06
MA30466B1 (fr) 2009-06-01
IL195270A (en) 2016-08-31
ZA200809721B (en) 2009-06-24
KR20090017593A (ko) 2009-02-18
EP2018158A1 (fr) 2009-01-28
WO2007132091A1 (fr) 2007-11-22
SI2018158T1 (sl) 2013-09-30
BRPI0710405B8 (pt) 2021-05-25
DK2018158T3 (da) 2013-07-22
NZ573424A (en) 2012-03-30
CN101442990A (zh) 2009-05-27
AU2007251471B2 (en) 2012-03-15
BRPI0710405A2 (pt) 2011-08-09
FR2900823A1 (fr) 2007-11-16
UA98299C2 (ru) 2012-05-10
CY1114190T1 (el) 2016-08-31
US20090186084A1 (en) 2009-07-23
EA200802324A1 (ru) 2009-04-28
US8318203B2 (en) 2012-11-27
FR2900823B1 (fr) 2009-02-13
MX2008014554A (es) 2008-11-27
RS52912B (en) 2014-02-28
CA2652023C (fr) 2016-06-28
AP2627A (en) 2013-03-26
KR101432116B1 (ko) 2014-08-21
PT2018158E (pt) 2013-07-24
BRPI0710405B1 (pt) 2019-01-08
ECSP088889A (es) 2009-01-30
IL195270A0 (en) 2009-08-03
PL2018158T3 (pl) 2013-09-30
ES2421929T3 (es) 2013-09-06
CA2652023A1 (fr) 2007-11-22

Similar Documents

Publication Publication Date Title
NO20084826L (no) Ny administrasjonsform av racecadotril
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
GB0625648D0 (en) Compounds
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
BR112012021337A8 (pt) formulações de apixaban.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
NO20084256L (no) DPP IV inhibitorformuleringer
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
MY164646A (en) Nicotine lozenge compositions
NO20060978L (no) Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
NO20084850L (no) MGLUR5 modulatorer I
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20084852L (no) MGLUR5 modulatorer V
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
MX2009001494A (es) 2-aminobenzoxazol carboxamidas como moduladores 5ht3.
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2007130822A3 (en) Mglur5 modulators iii